Buxco has been a leading innovator in pre-clinical life science research for more than 40 years. We work as your engineering partner to develop complete data acquisition and analysis solutions integrating software, hardware, application knowledge, and after-sale support. Applications cover pulmonary, cardiovascular, metabolic, and isolated organ research. Buxco's FinePointe™ software provides the industry's most advanced platform for all of these applications. Our set of software analyzers work individually or together to quantify key physiological parameters.
FinePointe™ software allows researchers to acquire, evaluate, and reanalyze data sets; set, move, and resize measurement periods; summarize data by subject groups; and generate statistical reports.
Our hardware is widely-used and covers a broad spectrum of research needs. Plethysmographs; transducers, sensors, and probes; preamplifiers; A/D converters; aerosol components; gas analyzers; and more; all fit together and are designed specifically for pre-clinical research.
Buxco's systems are cited extensively in published research so you can be assured your work fits into a large body of pre-clinical discovery.
For decades Buxco has driven innovation in the pre-clinical research market. That spirit of innovation continues with the introduction of our FinePointe™ series integrated systems, our Halcyon™ pneumotachographs, and the coming introduction of FinePointe™ NAM for noninvasive airway mechanics.
Buxco is headquartered in Wilmington, North Carolina USA and operates from locations across the United States, the United Kingdom, Japan, China, and Singapore. Other regions are served by a network of authorized technical distributors.
™FinePointe, and ™Halcyon are trademarks of Buxco Electronics, Inc. – less–ZoomInfo